10/6/2026
FDA seeks public input on ibogaine trial design
Request focuses on safety, dosing, and oversight for early-phase trials.
Topic archive
4 stories
10/6/2026
Request focuses on safety, dosing, and oversight for early-phase trials.
9/23/2026
No link established between ibogaine and Gerber's death, but heart risks persist.
9/21/2026
Psychedelic compound ibogaine draws interest amid regulatory shifts.
8/19/2026
Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.